Digital Pathology Today


Digital Pathology Today is your podcast all about the world of digital pathology.  Each week, we talk with industry leaders, key academics, top pathologists and more to discover the past, present and future of digital pathology.



  • Provide news, information and analysis about the state of digital pathology
  • Examine digital pathology’s past, present and future
  • Engage key leaders in digital pathology to discuss topics of interest to our listeners


Each episode of Digital Pathology Today will provide insight and information about the state of digital pathology from top leaders in the field.


Confirmed guests include:

“History of Digital Pathology”
Liron Pantanowitz, MBBCh
Director, Anatomic Pathology
Michigan Medicine
University of Michigan


The State of Digital Pathology Regulation
Joe Lennerz, MD, PhD
Medical Director, Center for Integrated Diagnostics
Massachusetts General Hospital
Co-Founder; Alliance for Digital Pathology


The Intersection of Precision Medicine and Digital Pathology
Anthony Magliocco, MD
President and CEO
Protean BioDiagnostics


Artificial Intelligence in Digital Pathology
Ajit Singh, PhD
Managing Director and General Partner
Artiman Ventures
Adjunct Professor; Stanford University Medical Center


Remote diagnosis Using Digital Pathology
Matthew Hanna, MD
Memorial Sloan Kettering Cancer Center


Invited guests include:

Derek Welch, MD
Chief Medical Officer


Claire Weston
Chief Executive Officer
Reveal Biosciences


Greg Osmond, MD
Chief Medical Officer
Pathology Watch


Dan Milner, MD
Chief Medical Officer
American Society for Clinical Pathology Center for Global Health Team


Michael Isaacs
Director of informatics
Washington University in St. Louis



Joseph Anderson, MDDr. Joseph Anderson is a consultant to early stage and mature companies in the digital pathology and molecular diagnostics space.  Previously, he oversaw the clinical pathology group at Genomic Health as the Oncotype Dx Breast cancer assay grew to a volume of over half a million tests. He was also involved in the development of new products, including assays for DCIS, Colon Cancer and one of the first commercially available liquid biopsies.  He served the College of American Pathologists on the Molecular Oncology Committee, with responsibility for proficiency testing in biomarkers for lung cancer in the United States and across the world and as member the House of Delegates representing California. He has served in several working groups and committees for the American Medical Association for CPT coding and reimbursement and assessment of new technologies such as next generation sequencing. Upon graduating from the University of Minnesota Medical School, he completed residency in Anatomic and Clinical Pathology at Rush University, fellowship in Oncologic Pathology at Fox Chase Cancer Center and post-doctoral training in Molecular diagnostics at UCSF. He initially worked in private practice, credentialed at 17 various hospitals and surgery centers. More details at:

Danny Schreiber is an award-winning journalist with over 25 years’ experience in broadcast and print.  He has worked at news operation KTTV and KTLA, where he won his Emmy award, in addition to Crain Communications where he led the team behind Crain’s NewsPro publication.  In addition, he has worked with Crain’s Modern Health Care, the Association of Health Care Journalists, National Association of Science Writer, National Academy of Television Arts and Sciences, and the Society of Environmental Journalists.
More details at:





Phone: 213-258-6268

562 University Drive, Unit 3

Menlo Park, CA 94025